Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Short Interest Down 47.3% in April

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) saw a large decline in short interest in the month of April. As of April 30th, there was short interest totaling 408 shares, a decline of 47.3% from the April 15th total of 774 shares. Based on an average trading volume of 2,035 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.1% of the company’s shares are sold short.

Innovator IBD Breakout Opportunities ETF Stock Performance

NYSEARCA BOUT traded down $1.09 on Friday, reaching $45.88. 915 shares of the stock traded hands, compared to its average volume of 5,036. The company has a fifty day moving average price of $41.89 and a 200-day moving average price of $39.48. The company has a market cap of $16.06 million, a price-to-earnings ratio of 28.69 and a beta of 1.05. Innovator IBD Breakout Opportunities ETF has a 12 month low of $34.57 and a 12 month high of $47.00.

Institutional Investors Weigh In On Innovator IBD Breakout Opportunities ETF

A number of institutional investors and hedge funds have recently bought and sold shares of BOUT. Comprehensive Wealth Management LLC raised its position in Innovator IBD Breakout Opportunities ETF by 122.0% during the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock valued at $850,000 after purchasing an additional 12,859 shares in the last quarter. Susquehanna International Group LLP raised its position in Innovator IBD Breakout Opportunities ETF by 42.6% during the 3rd quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after purchasing an additional 7,817 shares in the last quarter. Finally, Osaic Holdings Inc. raised its position in Innovator IBD Breakout Opportunities ETF by 39.7% during the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after purchasing an additional 597 shares in the last quarter.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.